SEC 13F Intelligence

Managers / Q4 2024

Sonic GP LLC

CIK 0001964290 · 400 HOBRON LANE, SUITE 3709, HONOLULU, HI, 96815 · 8086493381

Reported Value
$45M
Q4 2024
Positions
15
Filings on Record
9
2019–present window
Filed
Feb 14, 2025
original filing

Summary

Sonic GP LLC reported $45M in U.S.-listed holdings across 15 positions for Q4 2024.

The portfolio is heavily concentrated: FENC alone accounts for 33.5% of reported value.

The book was largely unchanged from Q3 2024.

Portfolio Metrics

Turnover
+7.7%
vs prior filed quarter
Top-10 Concentration
+94.7%
share of reported value
Largest Position
+33.5%
Fennec Pharmaceuticals

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’22: $133MQ4 ’22Q1 ’23: $131MQ2 ’23: $150MQ2 ’23Q3 ’23: $103MQ4 ’23: $87MQ4 ’23Q1 ’24: $76MQ2 ’24: $48MQ2 ’24Q3 ’24: $44MQ4 ’24: $45MQ4 ’24filingsflow.com

Portfolio Composition

By security type
Common Stock: 96.7%Other: 2.3%Equity WRT: 0.9%
  • Common Stock · 96.7% · $44M
  • Other · 2.3% · $1M
  • Equity WRT · 0.9% · $419,993

Quarter-over-Quarter Changes full breakdown →

vs Q3 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
REE AUTOMOTIVE LTDTRIMMED71.1K59.6K$396,495$526,056
UALUNITED AIRLS HLDGS INCTRIMMED60.0K51.8K$1M$5M
FENCFENNEC PHARMACEUTICALS INCHELD+02.41M+$3M$15M
RGNXREGENXBIO INCHELD+0403.1K$1M$3M
QUREUNIQURE NVHELD+050.0K+$636,500$883,000
FUNSIX FLAGS ENTERTAINMENT CORPHELD+050.0K+$394,000$2M
CCITIGROUP INCHELD+040.7K+$317,365$3M
BHFBRIGHTHOUSE FINL INCHELD+0100.0K+$301,000$5M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2024

14 positions
#IssuerClass% PortfolioValueShares
1FENCFENNEC PHARMACEUTICALS INChistory →COM33.54%$15M2.41M
2UALUNITED AIRLS HLDGS INChistory →COM11.08%$5M51.8K
3BHFBRIGHTHOUSE FINL INChistory →COM10.59%$5M100.0K
4ASTLALGOMA STL GROUP INCCOM · *W EXP 10/19/2029.55%$4M680.0K
5RGNXREGENXBIO INChistory →COM6.87%$3M403.1K
6CCITIGROUP INChistory →COM NEW6.32%$3M40.7K
7FUNSIX FLAGS ENTERTAINMENT CORPhistory →COM5.31%$2M50.0K
8PRKSUNITED PARKS & RESORTS INChistory →COM4.90%$2M39.6K
9PARAMOUNT GLOBALCLASS B COM4.61%$2M200.0K
10QUREUNIQURE NVhistory →SHS1.95%$883,00050.0K
11AUIDAUTHID INChistory →COM1.53%$692,300115.0K
12TROXTRONOX HOLDINGS PLChistory →SHS1.40%$634,96463.1K
13MURAL ONCOLOGY PUB LTD COORD SHS1.19%$537,688167.0K
14REE AUTOMOTIVE LTDSHS CL A NEW1.16%$526,05659.6K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2024$45M15Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$44M15Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$48M15Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$76M15May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$87M16Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$103M23Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$150M24Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$131M25May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$133M25Feb 14, 202313F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.